The committee leans into the FDA’s authorization of a “mix and match” approach to COVID-19 boosters, meaning people wouldn’t have to match their original shot.
The committee leans into the FDA’s authorization of a “mix and match” approach to COVID-19 boosters, meaning people wouldn’t have to match their original shot.